At a glance
ClinicalIndex Comparison RecordN/ACompleted· 54 enrolled
Drug / intervention
Hizikia Fusiformis extract +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy and Safety of Hizikia Fusiformis Extract in Subjects Showing Erosive Gastritis
In Brief
A clinical study evaluating Hizikia Fusiformis extract and Placebo for Erosive Gastritis. Completed, enrolled 54 participants.
Detailed Summary
The investigators performed a double-blind parallel study in a group of Subjects Showing Erosive Gastritis who were given Hizikia Fusiformis Extract over a period of 4 weeks. Endoscopic observations were performed before and 4 weeks after the treatment, and the cure and improvement rates were investigated.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsErosive Gastritis
Countries--
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2011
Primary CompletionAug 2011
Study CompletionApr 2012
First PostedSep 2012
TodayJul 2026
First PostedSep 21, 2012
Enrollment StartAug 1, 2011
Primary CompletionAug 1, 2011
Study CompletionApr 1, 2012
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 13.8 years ago
Interventions
Hizikia Fusiformis extractdietary
Hizikia Fusiformis extract(1.3g/d)
Placebodietary
Placebo(1.3g/d)